Although numerous clinical studies have aimed to treat AML, most results have been disappointing, according to authors of a publication in Blood.
The current state of AML treatment and remaining needs are discussed in an interview with Courtney D. DiNardo, MD, MSCE and Ghayas C. Issa, MD.
An assay from Mayo Clinic researchers screens multiple myeloma drugs to see how cells with different biomarkers and pretreatment histories react.
The American Society of Clinical Oncology published new clinical guidelines on the management of cachexia in adults with advanced cancer.
New developments in lab assays have allowed for more specialized assessments of VWD activity, leading to better diagnoses and various treatment options.